How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

723 results for

Cardiovascular rehabilitation

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Canadian guideline for Parkinson disease

a trial of dopamine replacement therapy to help with diagnosis. n Impulse control disorders can develop on dopami- nergic therapy at any stage in the disease but are more common in patients on dopamine agonists. n Deep brain stimulation and gel infusion are now routinely used to manage motor symptoms. n Rehabilitation therapists experienced with Parkinson disease can help newly diagnosed patients, and others through all stages. VISUAL SUMMARY OF RECOMMENDATIONS FROM THE CANADIAN GUIDELINE (...) with diagnosis. n Impulse control disorders can develop on dopami- nergic therapy at any stage in the disease but are more common in patients on dopamine agonists. n Deep brain stimulation and gel infusion are now routinely used to manage motor symptoms. n Rehabilitation therapists experienced with Parkinson disease can help newly diagnosed patients, and others through all stages. VISUAL SUMMARY OF RECOMMENDATIONS FROM THE CANADIAN GUIDELINE FOR PARKINSON DISEASE, 2ND ED PARKINSON DISEASE Parkinson-visual-9

2019 CPG Infobase

122. Haemodialysis

Hertfordshire NHS Trust Final Version: July 2019 Review Date: July 2024 Renal Association Clinical Practice Guideline Haemodialysis– July 2019 2 Claire Gardiner Senior Specialist Renal Dietitian, Leeds Teaching Hospitals NHS Trust Martin Gerrish RN Matron, United Lincolnshire Hospitals NHS Trust Dr Sharlene Greenwood Consultant Physiotherapist in Renal and Exercise Rehabilitation, King’s College Hospital, London. Dr Daljit Hothi Consultant Paediatric Nephrologist, Associate Medical Director, Great Ormond (...) guideline, as are many aspects of dialysis, including: ? Planning, initiation & withdrawal of Renal Replacement Therapy ? Vascular Access for Haemodialysis ? Cardiovascular Disease ? Blood Borne Viruses ? Assessment of the Potential Kidney Transplant Recipient ? Nutrition ? Anaemia ? CKD-Mineral and Bone Disorder ? Water Treatment Facilities, Dialysis Water and Dialysis Fluid Quality We have removed the section on targets for blood testing since these are better covered in other guidelines, and have

2019 Renal Association

123. Guidelines on Supraventricular Tachycardia (for the management of patients with) Full Text available with Trip Pro

and complications rates of catheter ablation for supraventricular tachycardia 23 Table 12 Classification of atrioventricular nodal re-entrant tachycardia types 30 Table 13 Recommendations for sports participation in athletes with ventricular pre-excitation and supraventricular arrhythmias 46 Table 14 European Working Group 2013 report on driving and cardiovascular disease: driving in arrhythmias and conduction disorders: supraventricular tachycardia 47 List of figures Figure 1 Differential diagnosis of narrow (...) Epidemiological studies on the SVT population are limited. In the general population, the SVT prevalence is 2.25/1000 persons and the incidence is 35/100 000 person-years. Women have a risk of developing SVT that is two times greater than that of men, and persons aged ≥65 years or have more than five times the risk of developing SVT than younger individuals. Patients with lone paroxysmal SVT vs. those with cardiovascular disease are younger, have a faster SVT rate, have an earlier onset of symptoms

2019 European Society of Cardiology

124. Diagnosis and Management of Acute Pulmonary Embolism Full Text available with Trip Pro

considerations 3.1 Epidemiology Venous thromboembolism (VTE), clinically presenting as DVT or PE, is globally the third most frequent acute cardiovascular syndrome behind myocardial infarction and stroke. In epidemiological studies, annual incidence rates for PE range from 39–115 per 100 000 population; for DVT, incidence rates range from 53–162 per 100 000 population. , Cross-sectional data show that the incidence of VTE is almost eight times higher in individuals aged ≥80 years than in the fifth decade (...) to come. PE may cause ≤300 000 deaths per year in the US, ranking high among the causes of cardiovascular mortality. In six European countries with a total population of 454.4 million, more than 370 000 deaths were related to VTE in 2004, as estimated on the basis of an epidemiological model. Of these patients, 34% died suddenly or within a few hours of the acute event, before therapy could be initiated or take effect. Of the other patients, death resulted from acute PE that was diagnosed after death

2019 European Society of Cardiology

125. Management of Dyslipidaemias Full Text available with Trip Pro

Management of Dyslipidaemias 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close (...) mobile search navigation Article Navigation Article Contents Article Navigation 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk : The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) François Mach Chairperson Switzerland Corresponding authors: François Mach, Cardiology Department, Geneva University Hospital, 4 Gabrielle-Perret-Gentil, 1211 Geneva

2019 European Society of Cardiology

126. Appropriate Use Criteria: Level of Care for Musculoskeletal Surgery and Procedures

., hemoglobin = 10) ? Coagulopathy ? Recent unexplained weight loss ? Malnutrition ? Chronic pulmonary disease Level of Care for Musculoskeletal Surgery Copyright © 2020. AIM Specialty Health. All Rights Reserved. 8 o COPD, severe and/or oxygen dependent o Respiratory distress ? Obstructive sleep apnea ? Liver disease including but not limited to cirrhosis ? Vascular o Cardiovascular disease ? Myocardial infarction within 6 months of intended surgery ? Angina pectoris with severe functional limitation (...) rehabilitation after surgery (example: moderate to severe myelopathy) ? Patient is at high risk for falls Outpatient Surgical Setting (excluding Observation) The nonobservation surgical setting includes Ambulatory Surgery Center or Hospital-based Outpatient Department and may be considered medically necessary for elective spine and joint surgery in low risk patients and procedures as follows: Note: These requirements do not prohibit providers from performing these procedures in Ambulatory Surgery Center

2020 AIM Specialty Health

127. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS) Society and the European Society of Thoracic Surgeons (ESTS) Full Text available with Trip Pro

nutrition may have a role in the malnourished patient postoperatively Low Weak Smoking cessation Smoking should be stopped at least 4 weeks before surgery High Strong Alcohol dependency management Alcohol consumption (in alcohol abusers) should be avoided for at least 4 weeks before surgery Moderate Strong Anaemia management Anaemia should be identified, investigated and corrected preoperatively High Strong Pulmonary rehabilitation and prehabilitation Prehabilitation should be considered for patients (...) at least 4 weeks before surgery High Strong Alcohol dependency management Alcohol consumption (in alcohol abusers) should be avoided for at least 4 weeks before surgery Moderate Strong Anaemia management Anaemia should be identified, investigated and corrected preoperatively High Strong Pulmonary rehabilitation and prehabilitation Prehabilitation should be considered for patients with borderline lung function or exercise capacity Low Strong Admission Preoperative fasting and carbohydrate treatment

2020 ERAS Society

128. SCAI Expert Consensus Statement Update on Best Practices for Transradial Angiography & Intervention Full Text available with Trip Pro

SCAI Expert Consensus Statement Update on Best Practices for Transradial Angiography & Intervention SCAI expert consensus statement update on best practices for transradial angiography and intervention - Shroff - - Catheterization and Cardiovascular Interventions - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term CLINICAL DECISION MAKING Free Access SCAI expert consensus statement update on best (...) practices for transradial angiography and intervention Corresponding Author E-mail address: Division of Cardiology, Department of Medicine, University of Illinois at Chicago, Chicago, IL Correspondence Adhir R. Shroff, MD, MPH, FSCAI, University of Illinois at Chicago, 840 South Wood Street, Chicago, IL 60612. Email: Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts Weill Cornell Medical College, New York Presbyterian

2020 Society for Cardiovascular Angiography and Interventions

129. Guidelines for Perioperative Care in Cardiac Surgery Enhanced Recovery After Surgery Society Recommendations

. doi: Halkos ME, Puskas JD, Lattouf OM, et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg . 2008;136(3):631-640. doi: Robich MP, Iribarne A, Leavitt BJ, et al; Northern New England Cardiovascular Disease Study Group. Intensity of glycemic control affects long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg . 2019;107(2):477-484. doi: Engelman DT, Adams DH, Byrne JG, et al. Impact (...) for the PREHAB study—Pre-operative Rehabilitation for Reduction of Hospitalization After Coronary Bypass and Valvular Surgery: a randomised controlled trial. BMJ Open . 2015;5(3):e007250. doi: Snowden CP, Prentis J, Jacques B, et al. Cardiorespiratory fitness predicts mortality and hospital length of stay after major elective surgery in older people. Ann Surg . 2013;257(6):999-1004. doi: Valkenet K, van de Port IG, Dronkers JJ, de Vries WR, Lindeman E, Backx FJ. The effects of preoperative exercise therapy

2020 ERAS Society

130. Hepatitis B: Scenario: Managing hepatitis B infection

infections is appropriate, and/or Drug rehabilitation agency (if appropriate). Ensure people with confirmed chronic hepatitis B have been vaccinated against hepatitis A if they are not already immune. For more information on administering hepatitis A vaccine, see the CKS topic on . Ensure contacts of people with confirmed chronic hepatitis B are offered hepatitis B vaccination and immunoglobulin if . This may include sexual partners, other household members (including children), and other contacts (...) . There have also been very rare cases of serious cardiovascular adverse effects, particularly after injection of the drug. The recommendations to try simple measures and to consider offering chlorphenamine to treat itch are based on the opinion of previous expert reviewers of this CKS topic. There was no consensus regarding the use of ursodeoxycholic acid, colestyramine, and corticosteroids, and as liver-associated itch can be difficult to treat, CKS pragmatically recommends seeking specialist advice

2020 NICE Clinical Knowledge Summaries

131. Hepatitis A: Scenario: Managing hepatitis A infection

infections is appropriate, and/or Drug rehabilitation agency (if appropriate). Follow-up at least every one to two weeks. Consider more frequent follow-up if the person is symptomatic and/or has jaundice, and depending on the results of ). Repeat liver function tests until amino-transferase levels are normal (usually 4 -12 weeks). Seek specialist advice if If the person has significantly abnormal liver function tests (for example aspartate aminotransferase [AST] or alanine aminotransferase [ALT] levels (...) in conditions requiring long-term treatment. There have also been very rare cases of serious cardiovascular adverse effects, particularly after injection of the drug. The recommendations to try simple measures and to consider offering chlorphenamine to treat itch are based on the opinion of previous expert reviewers of this CKS topic. There was no consensus regarding the use of ursodeoxycholic acid, colestyramine, and corticosteroids, and as liver-associated itch can be difficult to treat, CKS pragmatically

2020 NICE Clinical Knowledge Summaries

132. Heart failure - chronic: Scenario: Information and advice, follow-up, and referral

referral for people with comorbidities This recommendation is based on expert opinion in a review article which recommends optimizing the management of comorbidities [ ], and is pragmatic and based on what CKS considers to be good medical practice. Referral of women planning a pregnancy and women who are pregnant These recommendations are based on information in the guidelines from the European Society of Cardiology Guidelines on the management of cardiovascular diseases during pregnancy [ ], the Royal (...) interaction of prescribed medication with over-the-counter treatment for depression such as St John's wort, and recommends a review of all medication and adverse effects. Assessing the person's nutritional status This recommendation is based on information in the NICE guideline Chronic heart failure in adults: diagnosis and management [ ]. Offering a group exercise-based rehabilitation programme Information to ensure people have been offered a supervised group exercise-based heart failure rehabilitation

2020 NICE Clinical Knowledge Summaries

133. Heart failure - chronic: Scenario: Confirmed heart failure with preserved ejection fraction

) or hospitalization, and a small but statistically significant improvement in self-reported health status [ ]. A systematic review on the effects of moderate-high intensity resistance training in people with chronic heart failure found 10 trials, all with methodological flaws, which concluded that the evidence on benefits was weak and inconsistent but that there was no evidence of harm [ ]. The British Association for Cardiovascular Prevention and Rehabilitation (BACPR) Cardiac Rehabilitation Standards document (...) . If depression is likely to have been precipitated by heart failure symptoms then reassess psychological status once the physical condition has stabilised. If depression is co-existing with heart failure then the person should be treated taking into account potential risks and benefits of drug treatment. Further information is available in the CKS topics on and . If suitable, ensure the person has been offered referral to a supervised exercise-based group rehabilitation programme for people with heart

2020 NICE Clinical Knowledge Summaries

134. Heart failure - chronic: Scenario: Confirmed heart failure with reduced ejection fraction

on the effects of moderate-high intensity resistance training in people with chronic heart failure found 10 trials, all with methodological flaws, which concluded that the evidence on benefits was weak and inconsistent but that there was no evidence of harm [ ]. The British Association for Cardiovascular Prevention and Rehabilitation Cardiac Rehabilitation Standards document has defined that cardiac rehabilitation is associated with a reduction in morbidity, a 28-56% reduction in unplanned admissions (...) the person has been offered referral to a supervised exercise-based group rehabilitation programme for people with heart failure. The programme should offer psychological and education-based components. The person's heart failure should be . Comorbidities which may not be suitable for referral include uncontrolled ventricular response to atrial fibrillation, uncontrolled hypertension, and high-energy pacing devices set to be activated at rates likely to be achieved during exercise. Ensure the person

2020 NICE Clinical Knowledge Summaries

137. National Practice Guideline For the Treatment of Opioid Use Disorder

and responsibility to change is a goal beyond passive compli- ance. Given the importance of shared decision-making to improve collaboration and outcomes, patients are encour- aged to actively participate in treatment decisions and take responsibility for their treatment, rather than to pas- sively comply. Concomitant conditions: Medical conditions (e.g., HIV, cardiovascular disease) and/or psychiatric conditions (e.g., depression, schizophrenia) that occur along with a substance use disorder. Contingency

2020 American Society of Addiction Medicine

138. The Primary Care Management of Headache

for the Management of Concussion-mild Traumatic Brain Injury. Available at: https://www.healthquality.va.gov/guidelines/Rehab/mtbi/ VA/DoD Clinical Practice Guideline for the Primary Care Management of Headache July 2020 Page 9 of 150 Medication overuse headache, which has previously been called medication-misuse headache, rebound headache, or drug-induced headache, is an exceedingly common type of headache seen in primary and specialty care settings resulting from the excessive and inappropriate use of non (...) that is of particular interest to VA/DoD providers is a persistent headache attributed to a traumatic injury to the d See the VA/DoD Clinical Practice Guideline for the Management of Concussion-mild Traumatic Brain Injury. Available at: https://www.healthquality.va.gov/guidelines/Rehab/mtbi/ VA/DoD Clinical Practice Guideline for the Primary Care Management of Headache July 2020 Page 11 of 150 head, also known as a PTH. According to ICHD-3, to be defined as a PTH, the onset of the headache must be within seven days

2020 VA/DoD Clinical Practice Guidelines

139. The Non-Surgical Management of Hip & Knee Osteoarthritis

Gastrointestinal Events 88 C. Non-steroidal Anti-inflammatory Drugs and Risk of Cardiovascular Events 89 D. Non-steroidal Anti-inflammatory Drugs and Risk of Renal Disease 90 VA/DoD Clinical Practice Guideline for the Non-surgical Management of Hip & Knee Osteoarthritis July 2020 Page 5 of 127 Appendix G: Nutraceuticals and Dietary Supplements 92 A. Avocado and Soybean Extract 92 B. Boswellia Serrata Extract 92 C. Chondroitin, Glucosamine, and Glucosamine plus Chondroitin 92 D. Curcumin 92 E. Collagen 93 F (...) to the management of OA, from which Work Group members were recruited. The specialties and clinical areas of interest included: primary care, nursing, physical therapy, clinical pharmacology, internal medicine, dietetics, orthopedic surgery, rheumatology, family medicine, sports medicine, physical medicine and rehabilitation, and pain management. The guideline development process for the 2020 CPG update consisted of: 1. Formulating and prioritizing KQs and defining critical outcomes 2. Convening a patient focus

2020 VA/DoD Clinical Practice Guidelines

140. Endovascular Aortic Repair of Aneurysms Involving the Renal-Mesenteric Arteries (FEVAR) Full Text available with Trip Pro

by cardiovascular risk factors, pre-existing symptoms and medical history.( Chaikof E.L. Blankensteijn J.D. Harris P.L. White G.H. Zarins C.K. Bernhard V.M. et al. Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg. 2002; 35 : 1048-1060 , Fillinger M.F. Greenberg R.K. McKinsey J.F. Chaikof E.L. Society for Vascular Surgery Ad Hoc Committee on TRS Reporting standards for thoracic endovascular aortic repair (TEVAR). J Vasc Surg. 2010; 52 ( 33 e15 ) : 1022-1033 ) Clinical comorbidity score (...) systems Cardiac complications remain one of the main outcome measures and several clinical scoring systems have been developed to assess risk of cardiac events.( Chaikof E.L. Blankensteijn J.D. Harris P.L. White G.H. Zarins C.K. Bernhard V.M. et al. Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg. 2002; 35 : 1048-1060 , Fleisher L.A. Fleischmann K.E. Auerbach A.D. Barnason S.A. Beckman J.A. Bozkurt B. et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation

2020 Society for Vascular Surgery

Guidelines

Guidelines – filter by country